Pituitary-Adrenal Physiology during Pregnancy
- 1 May 2001
- journal article
- review article
- Published by Wolters Kluwer Health in The Endocrinologist
- Vol. 11 (3), 159-170
- https://doi.org/10.1097/00019616-200105000-00002
Abstract
In many species, including human beings, pregnancy results in an activation of the hypothalamus-pituitary-adrenal (HPA) axis, resulting in increased maternal cortisol secretion. This increase is important for maintaining an environment to support fetal growth and development, because adrenal excess or insufficiency results in disturbances in maternal and fetal homeostasis. The mechanism of the HPA axis activation is not completely understood, and in the human, may involve placental secretion of corticotropin releasing hormone. However, a common mechanism is likely to be the interaction of progesterone with mineralocorticoid receptors in the brain, resulting in an increase in set-point for cortisol. In the human, maternal cortisol can cross the placenta and affect fetal physiology before the fetal adrenal maturation. As the fetus matures, transplacental passage of cortisol decreases, and the fetal adrenal cortisol and androgen secretion increases. The maturing fetal HPA axis ultimately controls the timing of parturition by determining the rate of estrogen secretion from the placenta, thereby stimulating increased myometrial activity during labor. At term, interactions between the HPA and placental hormones may result in positive feedback cycles, which amplify and coordinate the increases in HPA secretion, myometrial activity, and fetal organ maturation.Keywords
This publication has 97 references indexed in Scilit:
- Preterm betamethasone treatment of fetal sheep: Outcome after term deliveryJournal of the Society for Gynecologic Investigation, 1996
- Effect of corticotropin-releasing factor-binding protein on prostaglandin release from cultured maternal decidua and on contractile activity of human myometrium in vitroJournal of Clinical Endocrinology & Metabolism, 1995
- Corticotropin-releasing hormone-induced vasodilatation in the human fetal-placental circulation: involvement of the nitric oxide-cyclic guanosine 3',5'-monophosphate-mediated pathwayJournal of Clinical Endocrinology & Metabolism, 1995
- Pharmacological and functional characterization of human mineralocorticoid and glucocorticoid receptor ligandsEuropean Journal of Pharmacology: Molecular Pharmacology, 1993
- Effect of bilateral lesions of the ovine fetal hypothalamic paraventricular nuclei at 118-122 days of gestation on subsequent adrenocortical steroidogenic enzyme gene expressionEndocrinology, 1992
- Corticotropin-releasing factor-binding protein is a glycoproteinBiochemical and Biophysical Research Communications, 1989
- Characterization and gestational regulation of corticotropin-releasing hormone messenger RNA in human placenta.JCI Insight, 1988
- Postnatal disappearance of the pregnancy-associated reduced sensitivity of plasma cortisol to feedback inhibitionLife Sciences, 1987
- Specific high-affinity binding protein for human corticotropin-releasing hormone in normal human plasmaBiochemical and Biophysical Research Communications, 1987
- Serum CBG, free and total cortisol and circadian patterns of adrenal function in normal pregnancyThe Journal of Steroid Biochemistry and Molecular Biology, 1982